BR112014029874A2 - composições farmacêuticas tópicas de tipo emulsão o/a que contém um retinoide. - Google Patents
composições farmacêuticas tópicas de tipo emulsão o/a que contém um retinoide.Info
- Publication number
- BR112014029874A2 BR112014029874A2 BR112014029874A BR112014029874A BR112014029874A2 BR 112014029874 A2 BR112014029874 A2 BR 112014029874A2 BR 112014029874 A BR112014029874 A BR 112014029874A BR 112014029874 A BR112014029874 A BR 112014029874A BR 112014029874 A2 BR112014029874 A2 BR 112014029874A2
- Authority
- BR
- Brazil
- Prior art keywords
- retinoid
- emulsion
- pharmaceutical compositions
- compositions containing
- topical pharmaceutical
- Prior art date
Links
- 150000004492 retinoid derivatives Chemical class 0.000 title 1
- 239000012049 topical pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/402—1-aryl substituted, e.g. piretanide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261654694P | 2012-06-01 | 2012-06-01 | |
| FR1255091 | 2012-06-01 | ||
| FR1255091A FR2991175B1 (fr) | 2012-06-01 | 2012-06-01 | Compositions pharmaceutiques topiques de type emulsion h/e contenant un retinoide |
| US61/654,694 | 2012-06-01 | ||
| PCT/EP2013/061199 WO2013178758A1 (fr) | 2012-06-01 | 2013-05-30 | Compositions pharmaceutiques topiques de type émulsion h/e contenant un rétinoïde |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BR112014029874A2 true BR112014029874A2 (pt) | 2017-06-27 |
| BR112014029874A8 BR112014029874A8 (pt) | 2021-08-24 |
| BR112014029874B1 BR112014029874B1 (pt) | 2022-01-18 |
Family
ID=46826691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014029874-2A BR112014029874B1 (pt) | 2012-06-01 | 2013-05-30 | Composição farmacêutica do tipo emulsão óleo em água, composições e uso da composição farmacêutica |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9855244B2 (pt) |
| EP (1) | EP2874619B1 (pt) |
| JP (1) | JP2015518033A (pt) |
| KR (1) | KR102118226B1 (pt) |
| CN (1) | CN104507470B (pt) |
| AU (1) | AU2013269581B2 (pt) |
| BR (1) | BR112014029874B1 (pt) |
| CA (1) | CA2875417A1 (pt) |
| FR (1) | FR2991175B1 (pt) |
| MX (1) | MX357704B (pt) |
| RU (1) | RU2655305C2 (pt) |
| WO (1) | WO2013178758A1 (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016131041A1 (en) * | 2015-02-13 | 2016-08-18 | Peter Kennedy | Topical vasodilator composition |
| US10478466B1 (en) | 2015-02-13 | 2019-11-19 | Peter Kennedy | Topical vasodilator composition |
| BR112018008556A2 (pt) * | 2015-10-30 | 2018-10-23 | Patagonia Pharmaceuticals Llc | ?composições farmacêuticas e métodos para tratar ictiose congênita? |
| CN114929678B (zh) * | 2019-11-29 | 2023-08-15 | 石家庄迪斯凯威医药科技有限公司 | 一种取代的间三联苯类化合物及其药物组合物和用途 |
| WO2024114789A1 (zh) * | 2022-12-02 | 2024-06-06 | 南京迈诺威医药科技有限公司 | 一种含有曲法罗汀的药物组合物及其应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5690923A (en) * | 1993-01-07 | 1997-11-25 | Yamanouchi Europe B.V. | Stable topical retinoid compositions |
| FR2709666B1 (fr) * | 1993-09-07 | 1995-10-13 | Oreal | Composition cosmétique ou dermatologique constituée d'une émulsion huile dans eau à base de globules huileux pourvus d'un enrobage cristal liquide lamellaire. |
| FR2742677B1 (fr) * | 1995-12-21 | 1998-01-16 | Oreal | Nanoparticules enrobees d'une phase lamellaire a base de tensioactif silicone et compositions les contenant |
| US5972355A (en) * | 1997-09-30 | 1999-10-26 | E-L Management Corp. | Stable compositions containing biologically active components |
| KR100452972B1 (ko) * | 2000-05-16 | 2004-10-14 | 주식회사 삼양사 | 경피투여용 하이드로젤 조성물 |
| US20040213754A1 (en) * | 2000-10-02 | 2004-10-28 | Cole Curtis A. | Method for cleansing sensitive skin using an alkanolamine |
| US6881414B2 (en) * | 2000-11-22 | 2005-04-19 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Mild cosmetic composition with stabilized retinoids |
| ES2319778T3 (es) * | 2002-03-12 | 2009-05-12 | GALDERMA RESEARCH & DEVELOPMENT | Composiciones que comprenden acido 6-(3-(1-adamantil)-4-metoxifenil)-2-naftanoici para tratamiento de enfermedades dermatologicas. |
| KR20070091613A (ko) * | 2004-11-08 | 2007-09-11 | 그렌마크 파머수티칼스 엘티디. | 항여드름 화합물 및 항생제 화합물을 함유하는 국소적 제약조성물 |
| FR2880020B1 (fr) * | 2004-12-23 | 2007-02-16 | Galderma Res & Dev | NOUVEAUX LIGANDS MODULATEURS DES RECEPTEURS RARs, UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE |
| AU2005318292B2 (en) * | 2004-12-23 | 2011-09-22 | Galderma Research & Development | Novel ligands that modulate RAR receptors, and use thereof in human medicine and in cosmetics |
| KR101365282B1 (ko) * | 2005-09-23 | 2014-02-19 | 디에스엠 아이피 어셋츠 비.브이. | 수산화지방산을 포함하는 화장품 조성물 |
| FR2910321B1 (fr) * | 2006-12-21 | 2009-07-10 | Galderma Res & Dev S N C Snc | Gel creme comprenant au moins un retinoide et du peroxyde de benzole |
| FR2910320B1 (fr) * | 2006-12-21 | 2009-02-13 | Galderma Res & Dev S N C Snc | Emulsion comprenant au moins un retinoide et du peroxyde de benzole |
| FR2915682B1 (fr) * | 2007-05-04 | 2009-07-03 | Galderma Res & Dev | Compositions depigmentantes dermatologiques et cosmetiques, leurs procedes de preparation, et leurs utilisations |
| RU2363461C2 (ru) * | 2007-10-03 | 2009-08-10 | Закрытое акционерное общество "Биологические исследования и системы" | Фармацевтический препарат для наружного и местного применения на основе сигетина |
| US9387160B2 (en) * | 2008-12-22 | 2016-07-12 | Johnson & Johnson Consumer Holdings France | Composition and method of treating skin conditions |
| EP2419082B1 (fr) * | 2008-12-23 | 2020-01-22 | Galderma S.A. | Composition pharmaceutique topique comprenant un principe actif sensible a l'eau |
-
2012
- 2012-06-01 FR FR1255091A patent/FR2991175B1/fr not_active Expired - Fee Related
-
2013
- 2013-05-30 WO PCT/EP2013/061199 patent/WO2013178758A1/fr active Application Filing
- 2013-05-30 MX MX2014014579A patent/MX357704B/es active IP Right Grant
- 2013-05-30 BR BR112014029874-2A patent/BR112014029874B1/pt active IP Right Grant
- 2013-05-30 US US14/404,877 patent/US9855244B2/en active Active
- 2013-05-30 AU AU2013269581A patent/AU2013269581B2/en active Active
- 2013-05-30 KR KR1020147036857A patent/KR102118226B1/ko active IP Right Grant
- 2013-05-30 JP JP2015514507A patent/JP2015518033A/ja active Pending
- 2013-05-30 CA CA 2875417 patent/CA2875417A1/fr not_active Abandoned
- 2013-05-30 EP EP13726205.1A patent/EP2874619B1/fr active Active
- 2013-05-30 RU RU2014152992A patent/RU2655305C2/ru active
- 2013-05-30 CN CN201380040802.9A patent/CN104507470B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013269581B2 (en) | 2018-03-01 |
| RU2014152992A (ru) | 2016-07-27 |
| FR2991175A1 (fr) | 2013-12-06 |
| BR112014029874A8 (pt) | 2021-08-24 |
| CN104507470B (zh) | 2018-06-26 |
| FR2991175B1 (fr) | 2014-12-19 |
| BR112014029874B1 (pt) | 2022-01-18 |
| RU2655305C2 (ru) | 2018-05-24 |
| US9855244B2 (en) | 2018-01-02 |
| MX2014014579A (es) | 2015-03-03 |
| AU2013269581A1 (en) | 2014-12-18 |
| US20150148400A1 (en) | 2015-05-28 |
| KR102118226B1 (ko) | 2020-06-02 |
| JP2015518033A (ja) | 2015-06-25 |
| EP2874619B1 (fr) | 2023-01-04 |
| WO2013178758A1 (fr) | 2013-12-05 |
| MX357704B (es) | 2018-07-20 |
| KR20150016984A (ko) | 2015-02-13 |
| EP2874619A1 (fr) | 2015-05-27 |
| CA2875417A1 (fr) | 2013-12-05 |
| CN104507470A (zh) | 2015-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL241881B (en) | Composition comprising at least two influenza a virus-neutralizing-binding molecules | |
| BR112015001596A2 (pt) | composição para o tratamento de hiperlipidemia que compreende oxintomodulina. | |
| DK2838961T3 (da) | Sammensætninger til maling | |
| DK3043778T3 (da) | Farmaceutiske sammensætninger, der indeholder refametinib | |
| DK2882433T3 (da) | Antimikrobielle sammensætninger omfattende glycerylnitrater | |
| BR112014029885A2 (pt) | composições tópicas, que contêm um retinoide, de tipo emulsão óleo em água | |
| DK2897594T3 (da) | Farmaceutisk sammensætning | |
| AU352808S (en) | Dispenser for curable compositions | |
| CL2014003495A1 (es) | Agentes herbicidas que contienen flufenacet. | |
| CL2015001166A1 (es) | Mezclas herbicidas que contienen auxinas | |
| BR112014029874A2 (pt) | composições farmacêuticas tópicas de tipo emulsão o/a que contém um retinoide. | |
| BR112014029879A2 (pt) | composições tópicas em forma de gel que contêm um retinoide particular solubilizado | |
| BR302013001136S1 (pt) | Configuração aplicada a dispensador de fluidos | |
| CL2015000231A1 (es) | Composición de recubrimiento que contiene biocida. | |
| BR112015014078A2 (pt) | composição farmacêutica oftalmológica tópica que contém regorefenib | |
| DK3441474T3 (da) | Farmaceutiske sammensætninger indeholdende et muteret leukocidin e | |
| DK2934510T3 (da) | Lfa-1-inhibitorformuleringer | |
| BR302013000270S1 (pt) | Configuração aplicada a embalagem. | |
| BR302012005282S1 (pt) | Configuração aplicada a um gatilho dispensador de adesivo. | |
| HK1204975A1 (en) | Oil/water-emulsion-type topical compositions containing retinoid | |
| UA24122S (uk) | Етикетка для майонезу | |
| DK2934147T3 (da) | Sammensætninger, der omfatter en triazolforbindelse | |
| UA27561S (uk) | Етикетка для упаковки майонезу | |
| UA27554S (uk) | Етикетка для упаковки майонезу | |
| BR302012005214S1 (pt) | Configuração aplicada em embalagem blister. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/05/2013, OBSERVADAS AS CONDICOES LEGAIS. |